戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1     Studies were screened with N = 11 meeting the inclusion/exclusion criteria.
2 68.3% women; mean age: 55.6+/-12.2 years) met our inclusion/exclusion criteria.
3                   All cases were included and there were no exclusion criteria.
4                                        There were no formal exclusion criteria.
5 ligible articles were identified that met the inclusion and exclusion criteria.
6 nosis of neurological disorder or cognitive impairment were exclusion criteria.
7 ) had asymmetric, bilateral amblyopia; 98 met inclusion and exclusion criteria.
8 nce to any study drugs; secondary analyses eliminated these exclusion criteria.
9 face diseases, intraocular diseases, trauma or surgery were exclusion criterias.
10                       After applying clinical and molecular exclusion criteria, 17.8% were assigned (26.4% could have bee
11                                          After applying the exclusion criteria, 3,558 men were recruited in intervention
12                                             After inclusion/exclusion criteria, 316 eyes were available for analysis; 131
13 c Balloon Pump in Cardiogenic Shock II) trial inclusion and exclusion criteria, 372 patients were identified and included
14                            After application of appropriate exclusion criteria, a cohort of 9447 inpatient operations was
15             LFII was a single-arm study using HBR inclusion/exclusion criteria and 30-day dual antiplatelet therapy after
16 er screening titles and abstracts against the inclusion and exclusion criteria and assessing full texts, 17 articles were
17                                               Inclusion and exclusion criteria and study duration were noted and tabulate
18 n fraction (HFrEF) trials with near identical inclusion and exclusion criteria and the same principal outcomes.
19                    Thirteen patients met both inclusion and exclusion criteria, and their tissue samples were revisited.
20 posed by Robins and Wang (RW) in a scenario where the study exclusion criteria are based on a variable that must be imput
21  or interventional studies, in which specific inclusion and exclusion criteria are used for patient selection.
22 rent smoker within the last 7 years, and 3) no prespecified exclusion criteria contraindicating LDCT screening.
23            These include choosing appropriate inclusion and exclusion criteria, dose optimization, risk of adverse effect
24 ile correlation as a proxy for drug similarity to establish exclusion criteria for ideal combination therapies.
25 he aim of this study was to determine the optimal inclusion-exclusion criteria for trials to aim for superiority in visua
26              We illustrate the substantial heterogeneity in exclusion criteria identified in a systematic literature sear
27                                                         Key exclusion criteria included if the patient was acutely suicid
28 criteria were severe symptomatic MR and high surgical risk; exclusion criteria included left ventricular ejection fractio
29                                                         Key exclusion criteria included systolic blood pressure <95 mm Hg
30                                                         Key exclusion criteria included uveal or mucosal melanoma, previo
31 stematic review of the literature to identify inclusion and exclusion criteria of prospective interventional oligometasta
32                                               Inclusion and exclusion criteria relating to type of paper, population, int
33 ommercial and Medicare payers, we implemented inclusion and exclusion criteria, selected primary end points, and comparat
34                                                       After exclusion criteria-specifically the removal of VFs with high
35                                                       After exclusion criteria, the cohort consisted of 747 patients (med
36                                                      Due to exclusion criteria, there were insufficient patients with sev
37 used on 5-Fluorouracil and Gemcitabine because based on our exclusion criteria, they provide the largest numbers of patie
38 eers were excluded for reasons relating to the inclusion or exclusion criteria, three (6%) volunteers were not treated be
39                                           After determining exclusion criteria, we analyzed demographic and clinical info
40                                                          No exclusion criteria were applied after including all invasive
41                                         After inclusion and exclusion criteria were applied, the study population include
42 e recalled (recall rate, 4.8%), and 827 were included after exclusion criteria were applied.
43                                               Inclusion and exclusion criteria were employed as follows; (1) study publis
44               A total of 274 patients meeting inclusion and exclusion criteria were identified and 132 patients were incl
45 were met by 71 633 (71.8%) patients, and both inclusion and exclusion criteria were met by 20 704 (20.8%) patients.
46                                                         The exclusion criteria were patients who (1) first presented with
47                                                         The exclusion criteria were presenting more than 14 days after in
48  30, 2017, 1,262 consecutive patients who met inclusion and exclusion criteria were studied.
49 d a total of 301 subjects and 319 vessels meeting inclusion/exclusion criteria which were included in the final analysis.
50                   Eight observational studies met inclusion/exclusion criteria with data for 2491 patients.